Elevated 20-HETE impairs coronary collateral growth in metabolic syndrome via endothelial dysfunction
2017
Elevated 20-hydroxyeicosatetraenoic acid (20-HETE) impairs coronary collateral growth (CCG) in metabolic syndrome by eliciting endothelial dysfunction and apoptosis via excessive neutrophil infiltration. 20-HETE antagonists completely restore coronary collateral growth in metabolic syndrome. microRNA-145 (miR-145) is an upstream regulator of 20-HETE production in metabolic syndrome; low expression of miR-145 in metabolic syndrome promotes elevated production of 20-HETE.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
87
References
26
Citations
NaN
KQI